147 related articles for article (PubMed ID: 18442062)
1. Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts.
Chee CE; Steensma DP; Wu W; Hanson CA; Tefferi A
Am J Hematol; 2008 Aug; 83(8):611-3. PubMed ID: 18442062
[TBL] [Abstract][Full Text] [Related]
2. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.
Tefferi A; Mesa RA; Pardanani A; Hussein K; Schwager S; Hanson CA; Steensma DP
Am J Hematol; 2009 May; 84(5):265-7. PubMed ID: 19396855
[TBL] [Abstract][Full Text] [Related]
4. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
5. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
6. Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
Leitch HA; Chase JM; Goodman TA; Ezzat H; Rollins MD; Wong DH; Badawi M; Leger CS; Ramadan KM; Barnett MJ; Foltz LM; Vickars LM
Hematol Oncol; 2010 Mar; 28(1):40-8. PubMed ID: 19557769
[TBL] [Abstract][Full Text] [Related]
7. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults.
Shaw GR
Br J Haematol; 2005 Oct; 131(2):180-4. PubMed ID: 16197447
[TBL] [Abstract][Full Text] [Related]
8. Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.
Pardanani A; Finke C; Abdelrahman RA; Lasho TL; Tefferi A
Am J Hematol; 2013 Apr; 88(4):312-6. PubMed ID: 23450619
[TBL] [Abstract][Full Text] [Related]
9. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.
Ljung T; Bäck R; Hellström-Lindberg E
Haematologica; 2004 Dec; 89(12):1446-53. PubMed ID: 15590394
[TBL] [Abstract][Full Text] [Related]
10. Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.
Pereira A; Nomdedeu M; Aguilar JL; Belkaid M; Carrió A; Cobo F; Costa D; Rozman M; Sanz C; Nomdedeu B
Am J Hematol; 2011 Mar; 86(3):245-50. PubMed ID: 21328437
[TBL] [Abstract][Full Text] [Related]
11. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.
Bacher U; Kern W; Alpermann T; Schnittger S; Haferlach C; Haferlach T
Leuk Res; 2012 Jul; 36(7):826-31. PubMed ID: 22554895
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype.
Tefferi A; Siragusa S; Hussein K; Schwager SM; Hanson CA; Pardanani A; Cervantes F; Passamonti F
Am J Hematol; 2010 Jan; 85(1):14-7. PubMed ID: 20029953
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
14. Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS.
Park S; Sapena R; Kelaidi C; Vassilieff D; Bordessoule D; Stamatoullas A; Cheze S; Beyne-Rauzy O; Vey N; Rose C; Guerci A; Natarajan-Amé S; Tertian G; Slama B; Fenaux P; Dreyfus F
Leuk Res; 2011 Nov; 35(11):1530-3. PubMed ID: 21803419
[TBL] [Abstract][Full Text] [Related]
15. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome.
Cakar MK; Yegin ZA; Baysal NA; Altındal S; Pamukçuoğlu M; Celik B; Yenicesu I
Transfus Apher Sci; 2013 Jun; 48(3):397-401. PubMed ID: 23619324
[TBL] [Abstract][Full Text] [Related]
16. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
[TBL] [Abstract][Full Text] [Related]
18. Studies on human preleukaemia. IV. Clinical and prognostic significance of sideroblasts in aregenerative anaemia with hypercellular bone marrow.
Hast R
Scand J Haematol; 1978 Nov; 21(5):396-402. PubMed ID: 734352
[TBL] [Abstract][Full Text] [Related]
19. Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts.
Cermak J; Kacirkova P; Mikulenkova D; Michalova K
Leuk Res; 2009 Nov; 33(11):1469-74. PubMed ID: 19646756
[TBL] [Abstract][Full Text] [Related]
20. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture.
Engoren M; Mitchell E; Perring P; Sferra J
J Trauma; 2008 Dec; 65(6):1411-5. PubMed ID: 19077635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]